Hypoxia--a key regulatory factor in tumour growth
- PMID: 11902584
- DOI: 10.1038/nrc704
Hypoxia--a key regulatory factor in tumour growth
Abstract
Cells undergo a variety of biological responses when placed in hypoxic conditions, including activation of signalling pathways that regulate proliferation, angiogenesis and death. Cancer cells have adapted these pathways, allowing tumours to survive and even grow under hypoxic conditions, and tumour hypoxia is associated with poor prognosis and resistance to radiation therapy. Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.
Similar articles
-
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.Nature. 1998 Jul 30;394(6692):485-90. doi: 10.1038/28867. Nature. 1998. PMID: 9697772
-
Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.Nature. 2001 Nov 29;414(6863):550-4. doi: 10.1038/35107085. Nature. 2001. PMID: 11734856
-
[Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].Bull Cancer. 1998 Oct;85(10):843-5. Bull Cancer. 1998. PMID: 9835861 Review. French.
-
A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.Cancer Res. 2002 Dec 1;62(23):6924-7. Cancer Res. 2002. PMID: 12460908
-
[The hypoxia-inducible factor HIF as a new target in cancer research].Bull Cancer. 2002 Mar;89(3):257-60. Bull Cancer. 2002. PMID: 11940464 Review. French.
Cited by
-
HIF-1α knockdown attenuates phenotypic transformation and oxidative stress induced by high salt in human aortic vascular smooth muscle cells.Sci Rep. 2024 Nov 15;14(1):28100. doi: 10.1038/s41598-024-79892-0. Sci Rep. 2024. PMID: 39543255 Free PMC article.
-
Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells.Front Immunol. 2024 Oct 29;15:1461455. doi: 10.3389/fimmu.2024.1461455. eCollection 2024. Front Immunol. 2024. PMID: 39534601 Free PMC article. Review.
-
Salmon patch maculopathy: An amblyogenic complication of pediatric sickle cell retinopathy.Am J Ophthalmol Case Rep. 2024 Oct 25;36:102203. doi: 10.1016/j.ajoc.2024.102203. eCollection 2024 Dec. Am J Ophthalmol Case Rep. 2024. PMID: 39526298 Free PMC article.
-
Targeted protein degradation: advances in drug discovery and clinical practice.Signal Transduct Target Ther. 2024 Nov 6;9(1):308. doi: 10.1038/s41392-024-02004-x. Signal Transduct Target Ther. 2024. PMID: 39500878 Free PMC article. Review.
-
Tumor-targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma.Nat Commun. 2024 Oct 31;15(1):9405. doi: 10.1038/s41467-024-53646-y. Nat Commun. 2024. PMID: 39477929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
